The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Jazz Pharmaceuticals PLC

Nasdaq: JAZZ
Last

(U.S.) $152.00

Today's change-0.97 -0.63%
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

Jazz Pharmaceuticals PLC

Nasdaq: JAZZ
Last

(U.S.) $152.00

Today's change-0.97 -0.63%
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.

Jazz Pharmaceuticals PLC down (U.S.)$0.97

Jazz Pharmaceuticals PLC closed lower Thursday, dropping (U.S.)$0.97 or 0.63% to (U.S.)$152.00. Shares have lost 2.64% over the last five days, but have gained 8.14% over the last year to date. This security has underperformed the S&P 500 by 15.01% during the last year.

Key company metrics

  • Open(U.S.) $151.58
  • Previous close(U.S.) $152.97
  • High(U.S.) $153.94
  • Low(U.S.) $150.98
  • Bid / Ask(U.S.) $80.43 / (U.S.) $199.67
  • YTD % change+8.14%
  • Volume398,224
  • Average volume (10-day)681,908
  • Average volume (1-month)760,467
  • Average volume (3-month)673,630
  • 52-week range(U.S.) $108.50 to (U.S.) $194.73
  • Beta0.72
  • Trailing P/E29.08×
  • P/E 1 year forward13.75×
  • Forward PEG0.71×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $5.23
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.01%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue341341334309
Total other revenue--------
Total revenue341341334309
Gross profit317312312281
Total cost of revenue24282228
Total operating expense234209197193
Selling / general / administrative124104107112
Research & development29512827
Depreciation / amortization24262425
Interest expense (income), net operating--------
Unusual expense (income)330171
Other operating expenses, total--------
Operating income107132136117
Interest income (expense), net non-operating-12-13-16-16
Gain (loss) on sale of assets--------
Other--------
Income before tax97118119103
Income after tax83888871
Income tax, total14303132
Net income83888871
Total adjustments to net income--------
Net income before extra. items83888871
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items83888871
Inc. avail. to common incl. extra. items83888871
Diluted net income83888871
Dilution adjustment--------
Diluted weighted average shares63636363
Diluted EPS excluding extraordinary itemsvalue per share1.321.391.401.12
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share1.571.391.591.13